Fosun
-
{
- All
- News
-
Concerns Raised Over Takeover Of Gland Pharma By China's Fosun, Says Report
The closing of the deal, which would be China's largest ever acquisition in India if approved, has now been extended to Sept. 26
-
China's Fosun Joins Race To Buy Cash-Strapped Fortis Healthcare
Fortis runs about 30 hospitals, having grown rapidly with demand created by an over-stretched public healthcare system
-
Fosun Pharma Completes Largest Ever Chinese Acquisition In India For $1.09 Billion
The Chinese firm decided to scale down its proposed acquisition in Gland Pharma to 74% following objections by government bodies.
-
Thomas Cook Up Most in 4 Months on Report of Buyout Interest
Suitors have asked about taking over Thomas Cook’s tour operating unit, as well as the entire company, Sky News reported.
-
Alibaba-Backed Babytree Seeks Up to $282 Million in H.K. IPO
The Beijing-based company is offering 250.3 million shares at HK$6.80 to HK$8.80 apiece.
-
U.S. Readies to Slap Duties on $16 Billion of Chinese Goods
The U.S. will begin imposing 25% duties on an additional $16 billion in Chinese imports in two weeks
-
Thomas Cook Should Book a Trip to Spinoff Island
As Thomas Cook considers selling stake in airlines, a cash injection is the vacation the travel company needs right now.
-
Fosun Is Said to Consider $500 Million India IPO of Gland Pharma
Gland Pharma could raise about $500 million from the IPO
-
BQuick On July 19: Top 10 Stories In 10 Minutes
BQuick | Top news, must-read stories and columns – all served up in less than 10 minutes.
-
Manipal Health Extends Validity Of Revised Offer For Fortis Till June 6
Manipal extends the validity of its offer, to give the Fortis board “sufficient time to consider the new offer.”
-
Fosun Pharma Is Said to Vie for $2 Billion Novartis Portfolio
Indian drugmaker Aurobindo Pharma Ltd. has also been picked to make final offer.
-
KKR-Backed Radiant Life Makes Multi-Layered Revised Bid For Fortis
KKR-Backed Radiant Life proposes multi-layered deal to Fortis Healthcare.
-
Is The Fortis Board Focused On Value Maximisation?
Fortis Healthcare has five suitors. Should it let them find out it’s true value?
-
Who’s Offered What In Takeover Battle For Fortis
Here are the four offers that Fortis Healthcare has on its table.
-
Is The Fortis Board Equipped To Manage A Competitive Bidding Scenario?
Fortis Healthcare’s board may lack the necessary wherewithal to make a decision, says IiAS.
-
Concerns Raised Over Takeover Of Gland Pharma By China's Fosun, Says Report
The closing of the deal, which would be China's largest ever acquisition in India if approved, has now been extended to Sept. 26
-
China's Fosun Joins Race To Buy Cash-Strapped Fortis Healthcare
Fortis runs about 30 hospitals, having grown rapidly with demand created by an over-stretched public healthcare system
-
Fosun Pharma Completes Largest Ever Chinese Acquisition In India For $1.09 Billion
The Chinese firm decided to scale down its proposed acquisition in Gland Pharma to 74% following objections by government bodies.
-
Thomas Cook Up Most in 4 Months on Report of Buyout Interest
Suitors have asked about taking over Thomas Cook’s tour operating unit, as well as the entire company, Sky News reported.
-
Alibaba-Backed Babytree Seeks Up to $282 Million in H.K. IPO
The Beijing-based company is offering 250.3 million shares at HK$6.80 to HK$8.80 apiece.
-
U.S. Readies to Slap Duties on $16 Billion of Chinese Goods
The U.S. will begin imposing 25% duties on an additional $16 billion in Chinese imports in two weeks
-
Thomas Cook Should Book a Trip to Spinoff Island
As Thomas Cook considers selling stake in airlines, a cash injection is the vacation the travel company needs right now.
-
Fosun Is Said to Consider $500 Million India IPO of Gland Pharma
Gland Pharma could raise about $500 million from the IPO
-
BQuick On July 19: Top 10 Stories In 10 Minutes
BQuick | Top news, must-read stories and columns – all served up in less than 10 minutes.
-
Manipal Health Extends Validity Of Revised Offer For Fortis Till June 6
Manipal extends the validity of its offer, to give the Fortis board “sufficient time to consider the new offer.”
-
Fosun Pharma Is Said to Vie for $2 Billion Novartis Portfolio
Indian drugmaker Aurobindo Pharma Ltd. has also been picked to make final offer.
-
KKR-Backed Radiant Life Makes Multi-Layered Revised Bid For Fortis
KKR-Backed Radiant Life proposes multi-layered deal to Fortis Healthcare.
-
Is The Fortis Board Focused On Value Maximisation?
Fortis Healthcare has five suitors. Should it let them find out it’s true value?
-
Who’s Offered What In Takeover Battle For Fortis
Here are the four offers that Fortis Healthcare has on its table.
-
Is The Fortis Board Equipped To Manage A Competitive Bidding Scenario?
Fortis Healthcare’s board may lack the necessary wherewithal to make a decision, says IiAS.
